tradingkey.logo

Novartis Announces Commencement Of Tender Offer To Acquire Regulus Therapeutics

ReutersMay 27, 2025 11:58 AM

- Novartis AG NOVN.S:

  • NOVARTIS ANNOUNCES COMMENCEMENT OF TENDER OFFER TO ACQUIRE REGULUS THERAPEUTICS

  • NOVARTIS AG - OFFER INCLUDES $7.00 CASH PER SHARE PLUS CONTINGENT VALUE RIGHT

  • NOVARTIS AG - PAR VALUE $0.001 PER SHARE

  • NOVARTIS AG - OFFER SUBJECT TO CUSTOMARY CONDITIONS INCLUDING HART-SCOTT-RODINO ACT

  • NOVARTIS AG - IN EXCHANGE FOR (I) $7.00 IN CASH PER SHARE

  • NOVARTIS AG - OFFER WILL EXPIRE AT ONE MINUTE PAST 11:59 P.M., NEW YORK CITY TIME, ON JUNE 24, 2025, UNLESS OFFER IS OTHERWISE EXTENDED OR EARLIER TERMINATED

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI